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Abstract
Using TLR pathways, primary human cytomegalovirus (HCMV) induces innate responses including the production of
inflammatory cytokines. Mounting evidence suggests that LPS recognition by TLR4/MD2/CD14 results in differential
utilization of TIRAP-TRAF6 and TRAM-TRIF signaling, thereby leading to transcriptional activation of various cytokine genes.
However, relative roles of the TLR4/MD2/CD14 complex and its adaptor proteins TIRAP and TRAM involved in regulating
monocyte responses to HCMV are incomplete. Here, we provided evidence supporting the notion that the TLR4/MD2/CD14
complex contributes notably to HCMV-induced signaling and subsequent cytokine production in monocytes. In particular,
induction of both IL-6 and IL-8 is associated with elevated TIRAP and reduced TRAM mRNA expression. The latter may serve
in a compensatory pathway that yields a robust IFN response when TIRAP signaling is blocked in monocytes incubated with
Toledo strain HCMV. Inhibitory studies using antisense oligonucleotides or neutralizing antibodies indicate that IL-6
induction by TLR4/MD2 complex is important for the activation of endogenous CD14 which later acts in concert or synergy
with TLR4/MD2 as a factor resulting in IL-8 gene expression. We further show that exogenous recombinant CD14 can
potentiate innate immune response via TLR4-dependent and possibly via TLR9-dependent pathways to promote enhanced
expression/production of IL-8 and IFN-b, respectively.
Citation: Yew K-H, Carpenter C, Duncan RS, Harrison CJ (2012) Human Cytomegalovirus Induces TLR4 Signaling Components in Monocytes Altering TIRAP, TRAM
and Downstream Interferon-Beta and TNF-Alpha Expression. PLoS ONE 7(9): e44500. doi:10.1371/journal.pone.0044500
Editor: Paul Proost, University of Leuven, Rega Institute, Belgium
Received January 10, 2012; Accepted August 8, 2012; Published September 7, 2012
Copyright: ß 2012 Yew et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the Katharine B. Richardson Foundation (Grant No. 01.4247). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hyew@kumc.edu

IFN-b [6], respectively. These cytokines themselves appear to play
an important role in the pathogenesis of HCMV after bone
marrow transplantation and can be useful predictors for HCMV
infection and disease [8].
CD14 is a 55-kDa glycoprotein found in nature either in a
membrane-bound form or a soluble form. Membrane-bound
CD14 (mCD14) is attached to the membrane by a glycosylphosphatidylinositol (GPI) anchor which excludes direct signal
transduction without the involvement of other membrane
constituents [9–11]. Soluble CD14 (sCD14) lacks the GPI anchor
but has the same amino acid sequence as mCD14. Both forms
enhance cell responsiveness to various bacterial/viral products
[3,4,10].
Another protein that has also been shown to be critical for the
TLR4/CD14 interaction is the extracellular adaptor protein
MD2. It is a small cysteine-rich glycoprotein that binds to the
ectodomain of TLR4 in the endoplasmic reticulum and then
transits to the cell surface in an active TLR4/MD2 complex
[4,9,12]. Both co-receptors are equally important to stabilize
TLR4 expression on the cell surface following engagement of
TLR4 with its prototype ligand, LPS [1–4,9].
Due to the conserved nature of the TLR4/MD2/CD14
complex, a growing number of reports suggest that the complex
is biologically relevant and responsive to viral proteins, including

Introduction
Toll like receptors (TLRs) are an evolutionary conserved family
of type 1 membrane receptors that are required for sensing the
presence of microorganisms and trigger inflammatory responses,
such as cytokine release [1]. To date, ten human TLRs (TLR1 to
TLR10) have been identified and characterized. This repertoire of
TLRs mediates recognition and inflammatory responses to a
broad spectrum of microbial and viral products [2] and is crucial
for effective host defense aimed at control of the invading
pathogens. Of these, TLR4 has widely been shown to be the
signal-transducing receptor activated by bacterial lipopolysaccharide (LPS). This finding led to the moniker for TLR4 as ‘the LPS
receptor’ [2,3]. In addition to TLR4, two accessory molecules,
MD2 and CD14, are also essential for LPS-induced TLR4
response [3,4].
Downstream signaling via TLR4 originates from its conserved
cytoplasmic domain, the TIR domain. It is peculiar among other
TLRs in its ability to facilitate the engagement of two distinct TIR
domain-containing adaptor proteins: TIRAP (also known as Mal),
which recruits MyD88 and TRAM (also called TICAM2 or
TIRP), which recruits TRIF [5]. The MyD88-TIRAP (MyD88
dependent) complex activates TRAF6 via IRAK kinases, whereas
the TRAM-TRIF (MyD88 independent) module recruits RIP1 or
TRAF6 [6], leading to the induction of IL-6 and IL-8 [7] as well as
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Figure 1. HCMV activates THP-1 cells via the TLR4/MD2/CD14 receptor complex. A and B: Immunostaining of THP-1 cells with and without
HCMV stimulation for TLR4 showed marked upregulation of TLR4-positive staining. C–E: Quantitative gene expression analysis using real-time qPCR
in TLR4, MD2, and CD14 reflected similar upregulation seen in A. All mRNAs were analyzed from the same preparation. All data are means6S.D. of
experiments performed in triplicate. Reaction mixtures without reverse transcriptase served as controls for genomic DNA contamination in all cases
(Data not shown).
doi:10.1371/journal.pone.0044500.g001

The purpose of the current investigation is to identify aspects of
signaling through TLR4 together with TLR4 accessory receptors/
factors with which they interact, and to determine how HCMV
may induce cytokine production from human monocytes. In
testing our hypotheses, we utilized our well-established THP-1
monocytic cell induction model and employed a variety of
molecular and cellular approaches to determine whether HCMV
induces TLR4/MD2/CD14 complex signaling through the
MyD88-dependent or the MyD88-independent pathway by
assaying gene expression of selected but representative downstream signaling molecules and cytokines.
We first noted that HCMV induces THP-1 cells signaling via
the TLR4/MD2/CD14 complex which initiates and regulates
additional downstream signaling via TRAF6 in a TIRAPdependent pathway, which in turn induces IL-6 and IL-8. We
also showed that TRAM signaling was notable only with impaired
TIRAP activity, thus possibly representing an ‘‘alternative’’
signaling route. This alternative pathway signaling also appears
to increase activation of IFN-inducible genes via the TRAM-TRIF
pathway, shifting from the canonical IL-6/IL-8 response to an
IFN-b dominant response. We further observed that IL-6
induction by TLR4/MD2 is required for CD14 activation. This

those of Ebola virus [13] in monocytes, hepatitis C virus [14] in
bone marrow cells and respiratory syncytial virus [15] in lung cells,
thereby leading to induction of proinflammatory cytokines.
Nevertheless, little is known about the mechanism by which the
components of the TLR4/MD2/CD14 complex mediate such
effects in monocytes when TLR4 signaling is induced by HCMV.
Previous studies from other investigators have clearly determined the involvement and importance of TLR2 and CD14 in
HCMV attachment, uptake and subsequent signaling leading to
expression of pro-inflammatory cytokine genes [16,17]. Likewise,
TLR4 and endosomal TLRs, such as TRL3 and TLR 9, are also
involved in HCMV-elicited signaling leading to a cellular proinflammatory and antiviral response [16,17]. Thus HCMV
appears to induce signaling via multiple TLRs, with characteristics
that differ by being MyD88 dependent or independent as well as
using TLRs that predominantly reside on cell surfaces or in
endosomes. These data prompted us to further investigate the role
of transduced molecules and modulatory factors within the
signaling pathways of the TLR4/MD2/CD14 complex as an
additional important signaling pathway during the immune
response to HCMV.
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Figure 2. Quantitative analysis of TLR4-mediated signaling molecules and cytokine transcriptions in THP-1 cells induced by HCMV.
All data are means6S.D. of experiments performed in triplicate. A: TIRAP levels were seen to increase even at the earliest times after incubation with
HCMV. B: TRAM conversely showed a marked reduction of mRNA levels in response to HCMV, particularly at 6 hours. C: TRAF6, which potentially
serves as a rate-limiting factor, was not found to be significantly altered at any time point. D and E: TLR4 regulating cytokine IL-6 and IL-8 expressions
were elevated at 1 hour and 6 hours, respectively. F and G: The production of IL-6 and IL-8 measured by ELISA correlated well with the results of D
and E. *p,0.05; ** p,0.01 by student T-test.
doi:10.1371/journal.pone.0044500.g002
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CD14 activation then acts in concert with TLR4/MD2 to
enhance IL-8 mRNA transcription via a TIRAP-TRAF6-dependent pathway. Furthermore, exogenous recombinant CD14
restores the ability of IL-6-deficient THP-1 cells to augment IL8 response through a TLR4-dependent pathway as well as
enhancing IFN-b induction possibly via a TLR9-dependent
mechanism.

HCMV Up-regulates TIRAP/Mal Expression in THP-1
Monocytes
In light of the role of HCMV in inducing TLR4 receptor
complex activation in our model (Fig. 1) and prior evidence of
enhanced IL-6 and IL-8 cytokine responses in HCMV-IE
transfected or HCMV-infected monocytes [19,20], we next
determined whether the TLR4-mediated activation of downstream adaptor molecules (TIRAP and TRAM) plays a regulatory
role in the inflammatory cytokine response to HCMV in THP-1
cells. TIRAP is strongly upregulated as early as 15 minutes post
THP-1 incubation with HCMV (Fig. 2A). Conversely, TRAM
mRNA (Fig. 2B) was significantly decreased in THP-1 cells
incubated with HCMV but not in monocytes incubated with virus
free supernatants of human foreskin fibroblasts (HFF) cells. To
determine whether either of these two adaptor molecules operates
in parallel to TRAF6, (potentially acting as a rate-limiting factor),
we assayed RNA levels of TRAF6, and found them more similar
to TIRAP than to TRAM (Fig. 2C) at each assay point post
incubation with HCMV. IL-6 expression in response to HCMV
infection (Fig. 2D) was similar to that observed for MD2
expression (Fig. 1D), peaking at 1 hour post incubation with
HCMV. In contrast, elevated IL-8 levels (Fig. 2E) were detected at
six hours, similar to the pattern observed for CD14 (Fig. 1E).
Levels of IL-6 (Fig. 2F) and IL-8 (Fig. 2G) proteins were found to
correlate with the mRNA (Fig. 2D & 2E) as determined by ELISA.

Results
Toledo Strain HCMV Added to THP-1 Monocytic Cells
Activates the TLR4/MD2/CD14 Complex
TLR4 engagement of diverse ligands (bacterial LPS and
components of many viruses) in multiple cell types initiates
formation of a TLR4/MD2/CD14-complex as an essential step in
signaling; this induces production of inflammatory cytokines [1–
4,13–15] via the MyD88-dependent pathway or the MyD88independent pathway [5,6]. Unlike TLR2, there are surprisingly
sparse data on HCMV-induced TLR4 signaling in monocytes. To
examine the role of TLR4 receptor complex in THP-1 cells
incubated with laboratory strain of HCMV that retains more wildtype genes than AD169 strain, we first used RT-PCR to evaluate a
broad time-response of THP-1 cells cultured in the presence or
absence of Toledo HCMV.
We determined that TLR4 upregulation via increased fluorescence intensity in the presence of HCMV (Fig. 1A & B) using
immunocytochemical (ICC) staining. Using SYBR Green I realtime assays, we determined the precise time of upregulation for
TLR4, CD14 and MD2 genes. We found that HCMV-induced
levels of TLR4 mRNA in the THP-1 cells peaked early at 15 min
and remained elevated throughout the incubation time (Fig. 1C).
In contrast, MD2 and CD14 responses peaked later at 1 hour and
6 hours of incubation with HCMV, respectively (Fig. 1D and 1E).
In order to determine whether a brief incubation of THP-1 cells
with HCMV results in actual infection, THP-1 cells were
incubated with HCMV-Toledo for 1 and 6 hours followed by
washing to clear residual HCMV in the media. Further incubation
of these THP-1 cells for 3 days revealed that the initial brief
incubations for leads to HCMV infection that can be detected by
PCR (Fig. S1 A & B, respectively). In addition, we wanted to
visualize HCMV immediate early antigen (IEA) and late antigen
(LA) expression in infected THP-1 cells. This was achieved by
exposing THP-1 cells to HCMV-Toledo for either 10 or 60
minutes followed by washing and incubation for 72 hours. After
the 72 hour incubation period, cells were fixed and immunolabeled with antibodies to detect immediate early antigens (IEA) or
late antigens (LA). Both exposure times resulted in positive
immunoreactivity for IEA and LA (Fig. S1 C and D, respectively).
Other experiments in triplicate revealed 15–25% of THP-1 cells
from these incubations are productively infected. Further,
microscopic examination reveals a physical change in morphology
from the non-adherent rounded form seen in unstimulated cells to
an angular form that is plastic adherent in 65–85% of cells after 4
days of total incubation. These data suggest that among THP-1
cells incubated for short times (15 minutes, 1 and 6 hours) with a
ratio of 10 virions per THP-1 cell, a small proportion are
productively infected but a larger proportion are stimulated. It is
likely therefore, that these brief incubations with HCMV resulted
in HCMV contact with most if not all the THP-1 cells, but uptake
of virions or viral components was likely by only a proportion of
the co-incubated THP1 cells. It is the latter uptake of virions or
viral components that may lead to ‘detection’ by intracellular/
endosomal TLRs [16,17,18].
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Effects of TLR4 Blockade on HCMV-induced Cytokine
Responses in THP-1 Cells
Prior data (Fig. 1) shows that incubation of THP-1 cells with
HCMV activates TLR4 receptors at various times of incubation
(15 min, 1 hour and 6 hours), together with upregulation of
TLR4/MD2-mediated IL-6 and TLR4/CD14-mediated IL-8
transcription at 1 hour and 6 hours, respectively. This suggests
that TLR4 may be a major mediator of HCMV-induced cytokine
responses in THP-1 cells. To further verify the importance of
TLR4 in HCMV-mediated cellular responses, we performed a
similar set of experiments with a focus on 1 hour (IL-6) and 6
hours (IL-8) of THP-1 incubation with HCMV using an antihuman TLR4-neutralizing antibody as an antagonist. Initial
experiments incubating TLR4 antibody with THP-1 cells showed
no loss of viability after 4 days of incubation. Further, incubation
of TLR4 antibody with THP-1 cells in the presence of poly I:C did
not significantly impair interferon responses (data not shown).
Anti-TLR4 treatment resulted in significant reduction of CD14
(Fig. 3A) and MD2 (Fig. 3B) mRNA expression in THP-1 cells
incubated with HCMV. These results demonstrate that CD14 and
MD2 are regulated by TLR4-dependent cell activation induced by
HCMV. Furthermore, HCMV-induced increases in TIRAP
mRNA (Fig. 3C) were dramatically reduced by TLR4 antibody.
In contrast TLR4 blockade did not modify HCMV-induced
decreases in TRAM (Fig. 3D) mRNA. This suggests that TLR4 is
an important receptor inducing TIRAP transcription after
HCMV-induced TLR4 activation. In contrast, TLR4 blockade
strongly diminished IL-6 (Fig. 3E, G) and IL-8 (Fig. 3F, H)
induction, suggesting that TLR4 is a contributor to HCMV’s role
in stimulating production of these cytokines. These observations
imply an important role for TLR4 in HCMV response via a
TLR4-TIRAP-dependent signaling pathway.

Soluble TLR4/MD-2 Receptors Competitively Inhibit
HCMV-induced IL-6 and IL-8 in THP-1 Cells
Despite published evidence of LPS’ recognition by TLR4/MD2
[1–4,9], little is known about HCMV interaction with TLR4/
4
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Figure 3. Effects of neutralizing TLR4 antibody compared to goat IgG control antibody on TLR4-induced gene transcription and
cytokine activation. A: The increase in CD14 mRNA levels upon incubation with HCMV for 6 hours was significantly reduced by the TLR4
neutralizing antibody. B–F: Similar results were obtained for MD2 (B), TIRAP (C), IL-6 (E) and IL-8 (F). However, no effect on TRAM (D) was seen.
(means6S.D. n = 4) (*p,0.05, **p,0.01 by students T test compared with control at 1 hour and 6 hours). G and H: ELISA analysis confirmed expected
decreased levels of IL-6 (G) and IL-8 (H). All data are means of experiments performed in triplicate except where noted.
doi:10.1371/journal.pone.0044500.g003
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Figure 4. HCMV induced effects of recombinant TLR4/MD2 soluble receptors on THP-1 cells. CD14 mRNA (A) increases at 6 hours were
blunted in the presence of TLR4/MD2 soluble receptors but not in media absent the exogenous soluble receptors, consistent with the results seen for
neutralizing TLR4 antibody in Figure 3. Similar effects were seen on TIRAP (B), IL-6 (E) and IL-8 (F), suggesting that TLR4/MD2 complex signaling was
essential for IL-6 and IL-8 induction. However, the soluble receptors had a minimal effect on TRAM (C) and TRAF6 (D). (means6S.D. n = 4). IL-6 (G) and
IL-8 (H) secretion measured by ELISA showed similar findings. All data are means+S.D. of experiments performed in triplicate unless otherwise noted.
*p,0.05; ** p,0.01 by student T-test.
doi:10.1371/journal.pone.0044500.g004

Neither TIRAP (Fig. 6A) nor TRAF6 (Fig. 6B) expression was
modified by TRAM-antisense in THP-1 cells incubated with
HCMV, suggesting that TRAM is not integrally involved in the
regulation of the canonical HCMV-induced TLR4-mediated
signaling pathway. We next used qPCR and ELISA to measure
IL-6 and IL-8 expression (Fig. 6C and 6D) and secretion (data not
shown) by TRAM-antisense or antisense-control treated THP-1
cells co-incubated with HCMV. Expression and secretion of both
cytokines was unmodified by antisense treatment. Further,
TRAM-antisense treatments did not modify activation of TRIF
(Fig. 6E) or IFN-b (Fig. 6F) compared to the missense-control
treatment. Together, these data indicate that neither the MyD88dependent nor the MyD88-independent cytokine responses, when
induced via the HCMV-induced canonical TLR4 signaling
pathways, are directly affected by TRAM signaling. The
effectiveness of the antisense in inhibiting TRAM protein is
shown in the Western blot with suppression of TRAM in the
presence of TRAM antisense (Fig. 6G).

MD2. We sought to define the role of TLR4/MD2 complex in
regulating HCMV-induced cytokine induction, particularly IL-6.
We determined that IL-6 is differentially regulated by TLR4/
MD2 (Fig. 2 and Fig. 3). First we tested whether TLR4/MD2
complex involvement in HCMV-mediated cytokine activation is
similar to that previously shown for LPS-induced TLR4/MD2
signaling [5–7]. To evaluate induction of cytokine expression and
production by HCMV in THP-1 cells, we used exogenous soluble
recombinant TLR4/MD2 complex to compete with resident
membrane-bound TLR4/MD2 complex. Soluble TLR4/MD2
complex suppressed HCMV-elicited CD14 mRNA expression
(Fig. 4A), particularly at 6 hours. It also reduced TIRAP (Fig. 4B),
but not TRAM (Fig. 4C) or TRAF6 (Fig. 4D) expression similar to
our previous findings with TLR4 neutralizing antibodies (Fig. 3C).
Exogenous recombinant soluble TLR4/MD2 inhibited both IL-6
(Fig. 4E and 4G) and IL-8 (Fig. 4F and 4H) expression and
secretion.

TIRAP/Mal Inhibition Activates TRAM Transcriptional
Regulation of TLR4-mediated Inflammatory Cytokine
Induction

The CD14 Molecule is Important for IL-8 and IFN-b Gene
Expression and Secretion Induced by HCMV in THP-1
Cells

We determined that in our experiments noted above, TRAM
expression is decreased in contrast to a large increase in TIRAP
expression at both 1 and 6 hours after incubation with HCMV. In
contrast, TIRAP antisense treatments of similarly HCMV-coincubated THP-1 cells led to a large rise in TRAM expression at 6
hours (Fig. 5A), but had no effect on the expression of TLR4,
CD14 and MD2 (data not shown). The previously noted upregulation of TRAF6 mRNA levels at 1 and 6 hours (Fig. 5B) post
incubation with HCMV was not observed after TIRAP antisense
treatments. This suggests that TIRAP is critical for mediating
TRAF6 transduction in THP-1 cells incubated with HCMV.
Similar inhibiting effects were seen with TRAF6-induced expression and secretion of IL-6 (Fig. 5C and 5G) and IL-8 (Fig. 5D and
5H) at both 1 and 6 hours of HCMV co-incubation.
We next examined the effects of TIRAP-antisense treatments on
TLR4-induced MyD88-independent TRIF and IFN-b expression
in THP-1 cells incubated with HCMV. Interestingly, like TRAM,
both TRIF (Fig. 5E) and IFN-b (Fig. 5F) levels were markedly
elevated by TIRAP antisense treatments, particularly at 6 hours.
Likewise, a robust IFN-b protein production (Fig. 5I) was detected
at 6 hours by ELISA in TIRAP-depleted THP-1 cells coincubated with HCMV. To confirm the inhibiting effects of the
TIRAP antisense (Fig. 5J), Western blotting was performed in
antisense-treated and sense-treated controls, confirming sequencespecific decreases in TIRAP by antisense.

Since the more pronounced IL-8 response of THP-1 cells to
incubation with HCMV seemed to be associated with the higher
expression of CD14 molecule at 6 hours, we examined the effect of
CD14 antisense treatment on IL-8 expression and production.
CD14 antisense reduced the expression of TLR4 (Fig. 7A) and
TIRAP (Fig. 7C) at 6 hours of co-incubation with HCMV as well
as the expression (Fig. 7F) and secretion (Fig. 7I) of IL-8. In
contrast, addition of CD14 antisense had no substantial effect on
the activation of MD2 (Fig. 7B), TRAM (Fig. 7D) or IL-6 (Fig. 7E).
This suggests that CD14 and TLR4 are important in TRAF6mediated TIRAP-induced IL-8 production. Moreover, increased
TRIF mRNA (Fig. 7G) in THP-1 cells, pre-treated withCD14
antisense, is not accompanied by increased IFN-b (Fig. 7H and 7J)
and in fact is accompanied by a marked suppression of IFN-b
expression and secretion.
Assays of the soluble form of CD14 (sCD14) protein in CD14antisense treated THP-1 cells after incubation with HCMV
revealed depleted levels (Fig. 7K). A Western-blot for CD14 in
THP-1 cells incubated with HCMV in the presence of CD14
antisense or missense confirmed a sequence-specific effect of the
antisense (Fig. 7L). Together, these findings show that HCMVinduced signaling via CD14 and TLR4 is necessary for TIRAPmediated induction of IL-8 and TRAF6-mediated activation of
IFN-b.
Assays of the soluble form of CD14 (sCD14) protein in CD14antisense treated THP-1 cells after incubation with HCMV
revealed depleted levels (Fig. 7K). A Western-blot for CD14 in
THP-1 cells incubated with HCMV in the presence of CD14
antisense or missense confirmed a sequence-specific effect of the
antisense (Fig. 7L). Together, these findings show that HCMVinduced signaling via CD14 and TLR4 is necessary for TIRAPmediated induction of IL-8 and TRAF6-mediated activation of
IFN-b.

In Monocytes Co-incubated with HCMV, TRAM is not
Involved in Canonical Signaling that Enhances IL-6/IL-8 or
IFN-b Production
After noting that TIRAP antisense treatments increased TRAM
expression and resultant IFN-b induction (Fig. 5), we sought to
determine whether TRAM antisense treatment affected HCMV
induction of TLR4-mediated MyD88-dependent signaling in
THP-1 cells.
PLOS ONE | www.plosone.org
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Figure 5. Role of TIRAP in TLR4-mediated regulation of cytokine gene expression in THP-1 cells induced by HCMV. A: TIRAP antisense
treatment dramatically enhances levels of TRAM mRNA. B–D: Unlike previous elevations of TRAF6 mRNA (B), it was greatly inhibited by the TIRAP
antisense. TIRAP-TRAF6-induced IL-6 (C) and IL-8 (D) mRNA elevation was also accompanied by a marked suppression. Interestingly, TRIF-induced (E)
activation of IFN-beta (F) was markedly elevated by the TIRAP antisense, suggesting that a reversal exchange took place through the action of an
alternative mechanism to activate IFN-inducible genes via the TRAM-TRIF pathway. (means6S.D. n = 4) (*p,0.05, **p,0.01 by student T-test
compared with control at 1 hour and 6 hours) open squares = missense, closed squares = TIRAP antisense. The ELISA results showed an inhibition of
both IL-6 (G) and IL-8 (H) releases whereas secretion of IFN-b was significantly enhanced. All data are means of experiments performed in triplicate
except where noted. J: Western blotting confirms the inhibitory effects of the antisense on TIRAP levels; (n = 3). b-actin served as control for equal
loading.
doi:10.1371/journal.pone.0044500.g005

Discussion

Interleukin 6-mediated Induction of CD14 Leads to IL-8
and IFN-b Expression by Monocytes Incubated with
HCMV

The emerging theme from this study is the further elucidation of
the relationship between HCMV and host toll-like receptor (TLR)dependent innate immune responses. Understanding the contribution of toll like receptors and accessory proteins involved in the
innate recognition of HCMV is of great interest because of the
potential to identify novel intervention points for treatment
strategies for cytomegalovirus infection. We previously reported
that TLRs-2/-3/-9 are important cellular receptors that mediate
innate immune responses and cytokine production in human
monocytes incubated with Toledo strain HCMV [18]. Others had
also revealed the critical role of TLR2 together with CD14 in
HCMV attachment and subsequent activation of NFkB in TLR2
and CD14 over-expressing human embryonic kidney cells [16,17].
However, questions remained with respect to other potential
TLRs activated by co-incubation of innate immune cells, e.g.
monocytes with HCMV. Classically, the TLR4/MD2/CD14
complex was studied in the context of LPS and viewed as a key
ligand for bacterial glycolipids [2–4]. However, a series of
experiments, including a knock-out mouse model, showed that
the TLR4/MD2/CD14 complex can also be involved in the
recognition and subsequent innate immune response to several
viral proteins, such as vesicular stomatitis virus, mouse mammary
tumor virus and respiratory syncytial virus [13–15].
Here, we present evidence of a previously undescribed
relationship between components of the TLR4 receptor complex
and HCMV in monocytes of human origin. In this study, we
demonstrated that THP-1 monocytic cells strongly expressed
TLR4, MD2, and CD14 after incubation with Toledo strain
HCMV. We also show which pathways are involved in subsequent
regulating of cytokine expression, including IL-6, IL-8 and IFN-b.
In THP-1 cells incubated with HCMV, levels of TLR4 mRNA
peaked early at 15 min and remained elevated throughout the 6
hours of incubation. In contrast, MD2 and CD14 responses
peaked somewhat later at 1 hour and 6 hours, respectively. Our
data also suggest that MD2 serves an important component in
modulating IL-6 expression whereas IL-8 induction depends more
on CD14. The results of this investigation suggest that HCMV was
able to activate TLR4 signaling and mediate cytokine induction in
human monocytic cells in a time-dependent manner and that this
effect was blocked by TLR4-neutralizing antibodies. Moreover, in
the presence of soluble TLR4/MD-2 receptors, there was
suppression of CD14, particularly at 6 hours. We postulate that
competitive interaction of HCMV with soluble TLR4/MD2
receptors prevented the process of late upregulation of CD14,
implying that there was less HCMV available for interacting with
cell-bound TLR4/MD2.
These findings appear in conflict with the LPS-induced TLR4/
MD2 cellular activation model wherein LPS is first bound to
CD14 and further interacts with the TLR4/MD2 complex [4,9].
It has been suggested that CD14 is required for LPS-LBP (LPSbinding protein) binding to the TLR4/MD2 complex. So, TLR4/
MD2 is thought to work downstream of this initial binding in LPS

In liver cells and in the U937 and Mono-Mac-6 human
myelomonocytic cell lines that are incubated with gram-negative
bacteria or LPS, IL-6 is induced, and functions in an autocrine
manner to induce CD14 expression [10,21]. Therefore, we tested
the possibility that IL-6 mediated similar effects after induction of
CD14 gene expression in THP-1 cells incubated with HCMV. A
well-characterized IL-6 neutralizing antibody down-regulated the
expression of CD14 (Fig. 8B) at 6 hours of incubation with
HCMV. In parallel, TIRAP (Fig. 8C), TRAF6 (Fig. 8E), IL-8
(Fig. 8F) and IFN-b (data not shown) expression levels were also
strongly decreased by IL-6 antibody. Down-regulation of IL-8
(Fig. 8G), IFN-b (data not shown) and membrane-resident surface
CD14 (Fig. 8H) were also detected by ELISA at 6 hours of
incubation HCMV in the presence of IL-6 antibody. None of the
other factors that we evaluated, i.e. TLR4 (Fig. 8A) and MD2
(data not shown) or the adaptor TRAM (Fig. 8D), decreased with
IL-6 antibody treatment. Thus, we provide evidence that
induction of CD14 mRNA by HCMV in THP-1 cells is mediated
in part by IL-6.

Exogenous Recombinant CD14 Rescues HCMV-induced
IL-8 and IFN-b Production in IL-6 Antisense-treated THP-1
Cells
Our data indicate that HCMV-induced signaling via TLR4/
MD2 appears to be important for TIRAP-mediated induction of
IL-6 (Fig. 4) which in turn is required for the activation of CD14
(Fig. 8). Increased CD14 production in concert with TLR4/MD2
could promote TIRAP-mediated IL-8 expression as well as
TRAF6-mediated IFN-b, possibly via TLR9 (Fig. 7). Because
CD14 was reduced in the presence of IL-6 antibody (Fig. 8) and
this led to a reduction of IL-8 and IFN-b (Fig. 7), a rescue-type
experiment was performed with addition of exogenous recombinant CD14 after IL-6 antisense treatment to determine the
potential for either a rescue effect or a supraphysiologic effect.
A concentration of 20 mg/ml of recombinant CD14 resulted in
complete rescue of IL-8 (Fig. 9D and 9G) and IFN-b (Fig. 9F and
9H), suggesting that exogenous recombinant CD14 can be a key
modulator in the transcription of TLR4-mediated cytokines IL-8
and IFN-b. Likewise, 20 mg/ml of recombinant CD14 rescues
TIRAP (Fig. 9A) and TRAF6 (Fig. 9C) in IL-6 antisense-treated
THP-1 cells Incubated with HCMV. Since TRIF has no effect
(Fig. 9E), we postulate that recombinant CD14 can potentiate
selected HCMV-induced innate responses in IL-6 antisensetreated THP-1 cells, through TLR4-, TLR2- and we hypothesize
possibly TLR9-dependent pathways [16,18], thereby promoting
IL-8 and IFN-b activation, respectively.
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Figure 6. HCMV-induced effects of TRAM in TLR4-mediated regulation of cytokine gene expression in THP-1 cells. A–F: The mRNA
levels of all of the key molecules remained stable in the presence of the TRAM antisense, which is the opposite result of what is seen with the TIRAP
antisense, suggesting that TRAM may not be a critical regulator in signaling triggered by HCMV in THP-1 cells. Open squares = missense, closed
squares = TRAM antisense. G: Western blot confirmed sequence-specific decreases in target TRAM by antisense. All data are means6S.D. of
experiments performed in triplicate.
doi:10.1371/journal.pone.0044500.g006
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Figure 7. Role for CD14 in mediating CMV-induced cytokine expression. TLR4 (A) and TIRAP (C) mRNA elevations at 6 hours of HCMV coincubation were suppressed in the CD14 antisense-treated THP-1 cells, but little effect was seen on TRAM (D) and MD2 (B). However, IL-8 (F) and IFNb (H) were abolished by the CD14 antisense whereas IL-6 (E) and TRIF (G) were unaffected, suggesting that CD14 is the responsible receptor for
inducing IL-8 and IFN-b transcription via the TLR4/TIRAP-dependent pathway and possibly the TLR9/MyD88-dependent pathway, respectively.
(means6S.D. n = 4) (*p,0.05, **p,0.01 by Student T-test compared with control at 1 hour and 6 hours) open squares = missense, closed
squares = CD14 antisense. ELISA analysis showed that the CD14 blockade reduced the in vitro production of IL-6 (I), IL-8 (J) and sCD14 (K). Western
blot for CD14 confirmed sequence-specific effect of the antisense (L). (n = 3). All data are means of experiments performed in triplicate except where
noted.
doi:10.1371/journal.pone.0044500.g007

secretion occurred after neutralizing or knocking down IL-6.
These data provide the first information about the role of IL-6 in
regulating HCMV-induced CD14 expression in THP-1 monocytic
cells, and again show that CD14 is important for IL-8 and IFN-b
induction.
Multiple lines of biochemical and genetic evidence support the
contention that both soluble CD14 and GPI-anchored membrane
CD14 are accessory molecules that function to enhance cellular
responses to LPS [9–11]. No data were available to show whether
sCD14 could substitute for mCD14 function in facilitating
HCMV’s effects on TLR4 and MD2 in monocytes. To address
this issue, we added exogenous recombinant CD14 after IL-6
antisense treatment of THP-1 cells incubated with HCMV, in
order to determine the potential for rescuing IL-8 and IFN-b
expression and secretion. We showed a complete rescue of
TIRAP-mediated IL-8 and TRAF6-mediated IFN-b at 20 mg/
ml of sCD14, indicating that CD14 is a key modulator in the
transcription of TLR4/MD2-mediated cytokines IL-8 and IFN-b
if IL-6 is knocked down in THP-1 cells incubated with HCMV.
Since we saw that sCD14 has no effect of TRIF, we postulate that
it may strongly potentiate innate response in IL-6 antisense-treated
THP-1 cells, through TLR4- (current study) and/or TLR2 [16,18]
thereby promoting IL-8 and IFN-b activation, respectively.
There is a possibility that TLR9 could be involved in this CD14
related IL-8 and IFN-b production. CD14 was recently shown not
only to be associated with TLR9 signaling but also engaged in the
induction of type I IFN in peritoneal macrophages via the
MyD88-dependent pathway [23]. Further testing in the THP-1
model would be needed to evaluate CD14 as a possible factor in
the TLR9-dependent signaling pathway which is another mechanism in monocytes for the activation of TRAF6 leading to the
induction of IFN-b, instead of TRIF-induced IFN-b activation.
This observation adds evidence for a potential dual role of CD14
molecule in TLR2- or TLR4-induced TIRAP-mediated activation
of IL-8, possibly even TLR9-induced TRAF6-mediated IFN-b
activation.
There are limitations to our study. We used a single monocytic
cell line so that these same responses may not be generalizable to
other human monocyte populations. Future studies will be needed
to explore this. We also used a single laboratory strain of HCMV.
We chose Toledo strain because it retains a number of genes seen
in wild type HCMV that have been lost from other laboratory
strains such as AD169. Use of wild type clinical strains of HCMV
also will be needed to confirm that disease producing HCMV
strains induce similar responses. We use relatively short periods of
incubation of THP-1 cells with Toledo strain HCMV. Thus, we
are not able to differentiate the proportion of THP-1 cells that
might eventually become productively infected with longer
incubations. Further, we did not specifically determine the
proportion of targeted THP-1 cells in which entry of HCMV or
a viral component took place but did not progress, or those for
which a virion or some HCMV component merely engaged the
surface of the cells. The 10:1 MOI however should allow some
contact of each target THP-1 cell with HCMV. We plan studies
using either glycoprotein B or UV inactivated HCMV to help

induced TLR4 signaling [4,9]. It is possible that the CD14
membrane domain in THP-1 cells does not directly bind to an
HCMV component, but that it may secondarily increase the
binding to HCMV after an initial TLR4/MD2 binding takes
place. Involvement of all three components (TLR4/MD2 and
CD14) appears necessary as part of the HCMV-related activation
which modulates IL-8 expression. These findings also revealed
that the same three components appear required for initial IL-6
expression and later IL-8 expression, presumably via the TIRAPTRAF6 pathway in THP-1 cells. In contrast, no changes in the
levels of IL-6 were observed in CD14 antisense treated THP-1
cells after incubation with HCMV, suggesting that CD14
contributes minimally to IL-6 expression and release.
Another noteworthy finding was that TIRAP played a
regulatory role in the HCMV-induced inflammatory cytokine
response in THP-1 monocytic cells. HCMV-induced recruitment
of TIRAP to TLR4 is required for induction of TRAF6 as well as
expression and production of IL-6 and IL-8. However, when
TIRAP was depleted by antisense, there was a large rise in TRAM
expression at 6 hours. Of interest there was also a parallel increase
in both TRIF and IFN-b. The high level of TRAM at 6 hours is
surprisingly not accompanied by an elevation in TRAF6
expression, but rather a marked suppression of TRAF6. This
phenomenon accompanying TIRAP inhibition appears to be a
shift from the initial canonical MyD88-dependent pathway by
which TIRAP is activated in response to HCMV. The upregulation of TRAM may be compensatory, acting as an alternative
signal away from the ‘‘default’’ MyD88-dependent pathway when
there is a deficiency of TIRAP activity. This ‘‘alternative’’ route
appears to activate IFN-inducible genes via the TRAM-TRIF
pathway. There is some support for such a concept given
previously reported crosstalk between the TRAM-TRIF and
TIRAP-MyD88 pathways [22].
The role of TRAM in LPS signaling has been thought to be as a
bridging adapter between TLR4 and TRIF within the MyD88
independent pathway. TRAM activity has not been considered
crucial for other TLR signaling. TRAM deficient mice have
reportedly normal inflammatory cytokine production after ligand
engagement of TLR2, TLR7 and TLR9 [2] and normal TLR4
mediated phosphorylation of IRAK, indicating that a signaling
factor of the MyD88-dependent pathway that uses TRAF was also
unaffected. Interestingly, our TRAM antisense results also had no
effect on cytokine expression and secretion, strongly suggesting
that TRAM is not be an important adaptor in the HCMVinduced canonical TLR4-mediated pathway.
CD14 expression/production has been shown by others to
increase and correlate with prior IL-6 production in different
inflammatory conditions of liver cells [10], and human myelomonocytic cells, such as U937 and Mono-Mac-6 cells [21]. IL-6
has been shown to regulate (increase) CD14 expression and
synthesis in both HepG2 hepatocellular carcinoma cells and in
human primary hepatocytes [10]. Here, we show that IL-6 is
important for downstream CD14 expression and cytokine
production in THP-1 monocytic cells incubated with HCMV,
i.e. downregulation of CD14, IFN-b and IL-8 expression and
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Figure 8. Role of IL-6 in THP-1 cells incubated with HCMV. No change was seen for TLR4 (A) and TRAM (D) in the presence of IL-6 antibody.
However, the IL-6 antibody had an inhibitory effect on CD14 (B), TIRAP (C), TRAF6 (E) and IL-8 (F). (means6S.D. n = 4) (*p,0.05, **p,0.01 by student
T-test compared with control at 6 hours). The secretion of cytokines IL-8 (G) and sCD14 (H) from IL-6-antibody-treated THP-1 cells was analyzed by
ELISA and the results were similar to those observed by real-time PCR. Elisa data are means of experiments performed in triplicate.
doi:10.1371/journal.pone.0044500.g008

After the 3 day incubation period, cells were rinsed once more,
pelleted and cellular DNA was isolated. PCR was conducted on
THP-1 cellular DNA using primers specific for a sequence in
HCMV glycoprotein B (gB).

understand whether non-infectious virions or even single components produce similar effects. We also did not knock down TLR2
which we and others have shown can activate in the presence of
HCMV. Therefore, some of the reported effects may be due to
crosstalk between TLR2 and TLR4 activation. Further double
knock-down studies are thus also warranted.
Nevertheless we feel that our data add new information and
raise additional questions about the innate response to HCMV
and provide more understanding of importance of TLR4 and its
accessory/adaptor molecules in HCMV induced monocyte
responses.

Virus Preparations
Viral concentrations in the supernatant of human fibroblast
cultures infected with HCMV-Toledo at 5–7 days postinfection
were collected using the MilliporeH (Billerica, MA) SteriflipH
disposable vacuum filtration system with PVDF membrane to
remove cellular debris produced during infection of fibroblasts and
later using QIAamp DNA Micro Kit for the extraction of total
viral DNA, following the manufacturer’s recommendation.
HCMV-Toledo DNA copy number was then determined and
detected by the same protocol used in the SYBR Green real-time
quantitative PCR, except for the addition of HCMV primers and
the HCMV-Toledo DNA sample. All virus stocks were aliquotted
and stored at 280uC until used as viral inocula.

Materials and Methods
Reagents and Kits
Dulbecco’s Modified Eagle’s Medium (DMEM), Fetal Bovine
Serum, SYBR Green, Reference Dye for Quantitative PCR, and
Protease Inhibitor Cocktail were obtained from Sigma-Aldrich (St.
Louis, MO). RPMI Medium 1640 was obtained from Gibco/
Invitrogen. RNeasy Mini Kit, Sensiscript Reverse Transcriptase
Kit, QIAamp DNA Micro Kit, and QIAquick Gel Extraction Kit
were all purchased from Qiagen (Valencia, CA). AmpliTaq Gold
with GeneAmp 10X PCR Buffer and MgCl2 solution were from
Applied Biosystems (Foster City, CA).

Endo-Porter Delivery of Morpholino Antisense
Oligonucleotides Assay
Morpholino antisense oligonucleotides complementary to
TIRAP (59- GGGTCAAAACTAGCCCCGTGAGACC-39),
TRAM.
(59-TTATTTTAGACTTCCCGATACCCAT-39),
CD14 (59-CATGGTCGATAAGTCTTCCGAACCT-39), IL-6
(59- GGGAGATAGAGCTTCTCTTTCGTTC -39) and missense
control oligonucleotides. (59-CCTCTTACCTCAgTTACAATTTATA-39) were designed and synthesized by Gene Tools
(Philomath, OR). Special delivery morpholino antisense oligonucleotides were transfected with Endo-Porter transfection method
according to the manufacturer’s protocol. All morpholinos were
complexed with Endo-Porter delivery reagent and confirmation of
delivery was measured by the Western blot analysis. Note that all
Endo-Porter transfection experiments were carried out in triplicate
and repeated three times.

Cell Culture and Treatment
Human monocytoid THP-1 cells and human foreskin fibroblasts at passage 6 to 8, purchased from ATCC (Manassas, VA),
were grown in RPMI and DMEM, respectively, with 2 mM Lglutamine, 250 mg/ml amphotericin, 100 U/ml penicillin,
100 mg/ml streptomycin and 10% fetal bovine serum at 37uC
under a humidified condition of 95% air and 5% CO2. Upon
90% confluence, THP-1 cells were plated at a density of
,105 cells/well in 12-well plates with serum-free RPMI overnight.
On the following day, cells were either treated with serum-free
medium alone or serum-free medium plus HCMV-Toledo at a
multiplicity of infections (MOI) of 10 throughout the culture
period. Morpholino antisense or missense control was added
separately to culture media at 5 mmol/l. For inhibitory studies,
soluble recombinant human TLR4/MD2 complex was added at a
final concentration of 20 mg/ml with added media alone as a
control. For experiments where antibody neutralized TLR4 or IL6, 7.5 mg/ml human TLR4 neutralizing antibody or 2 mg/ml
human IL-6 neutralizing antibody were use based on the
manufacturer’s data (R&D Systems, Minneapolis, MN) as those
required to achieve .80% blocking in the blockade assay. Goat
IgG antibody was added to the control cells in similar
concentrations as control antibody. Freshly isolated THP-1 cells
were pretreated with the antibodies for two hours and HCMVToledo was added to culture media at MOI of 10 for the entire
culture time. In an additional experiment, exogenous recombinant
human CD14 (R&D Systems, Minneapolis, MN) was added at a
final concentration of 20 mg/ml, which has been established by
others to enhance LPS-stimulated cytokine secretion by THP-1
cells [24]. In order to determine whether a brief incubation of
THP-1 cells with HCMV results in actual infection, we coincubated THP-1 cells and HCMV-Toledo for 1 and 6 hours
followed by rinsing and subsequent incubation of cells for 3 days.
PLOS ONE | www.plosone.org

Non-quantitative PCR
Total RNA was extracted from cells and treated with DNase.
RNA was subjected to reverse transcription. cDNA was then
amplified by PCR for 40 cycles (Table 1). All PCR products were
separated by electrophoresis in 2% agarose gel. PCR cycles were
as follows: initial denaturation at 95uC for 10 minutes, followed by
40 cycles of 94uC for 30 seconds, 60uC for 30 seconds, 72uC for 30
seconds and final extension at 72uC for 10 minutes.

SYBR Green Real-Time Quantitative PCR
PCR amplifications were performed using a Bio-Rad iCycler
(Hercules, CA) sequence detection system. Unless otherwise
specified, each reaction mixture contained 10X Gold Buffer,
25 mm MgCl2, 2.5 mM dNTPs, 10X SYBR Green, AmpliTaq
Gold polymerase, Reference Dye, dH2O, DNA template and
10 mM of each primer. Amplification was performed by initial
polymerase activation for 10 minutes at 95uC, and 40 cycles of
denaturation at 95uC for 15 seconds, annealing at 60uC for 20
seconds and elongation for 30 seconds at 72uC. The fluorescence
threshold value was calculated using the iCycle system software.
The calculation of relative change in mRNA was performed using
14
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Figure 9. Rescue effects of exogenous recombinant CD14 in THP-1 cells incubated with HCMV and treated with IL-6 antisense. TIRAP
(A), TRAF6 (C), and IL-8 (D) levels at 6 hours were up-regulated by the addition of 20 ug/ml CD14. Rescue of IFN-b (F) levels at 6 hours was also seen.
However, rescued cells showed no change in TRAM (B) and TRIF (E) levels. (means6S.D. n = 4) (*p,0.05, **p,0.01 by student T-test compared with
control at 6 hours). ELISA revealed a dramatic increase in IL-8 (G) and IFN-b (H) production. Elisa data are means of experiments performed in
triplicate.
doi:10.1371/journal.pone.0044500.g009
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Table 1. PCR Primer Sequences.

Genes

GenBank Accession #

B-actin

NM_001101

Primer Sets

Product Size (bp)

FP: AGAAAATCTGGCACCACACC
RP: GGGGTGTTGAAGGTCTCAAA

HCMV gB

X04606

TLR4

NM_138554

CD14

NM_000591

142

FP: TGGTCTACAAGCGCAACATC
RP: GCCACGTATTCCGTATTGCT

130

FP: CGGAGGCCATTATGCTATGT
RP: TCCCTTCCTCCTTTTCCCTA

141

FP: AGCCACAGGACTTGCACTTT
RP: TGGGCAATGCTCAGTACCTT

MD2

NM_15364

123

FP: CCGAGGATCTGATGACGATT
RP: TGGGCTCCCAGAAATAGCTT

TIRAP

AB446477

TRAM

AY232653

TRAF6

NM_145803

TRIF

AB093555

IFN-b

M28622

IL-6

NM_000600

IL-8

NM_000584

142

FP: TGGTGCAAGTACCAGATGCT
RP: GACTTGACGAAAGCCACCAT

162

FP: CTCTTGGGGTAAAAGGCACA
RP: TGTTGGCCCCTCTGTTGTAT

124

FP: TCGAACCCTTGAGGACAAAG
RP: CGGGTTTGCCAGTGTAGAAT

160

FP: ACGCCACTCCAACTTTCTGT
RP: TCAGGTGAGCTGAACAAGGA

136

FP: CATTACCTGAAGGCCAAGGA
RP: AGCAATTGTCCAGTCCCAGA

150

FP: CTGCGCAGCTTTAAGGAGTT
RP: TAAGTTCTGTGCCCAGTGGA

135

FP: AAGAAACCACCGGAAGGAAC
RP: ACTCCTTGGCAAAACTGCAC

123

(FP = Forward Primer; RP = Reverse Primer; bp = basepair).
doi:10.1371/journal.pone.0044500.t001

and incubated with mouse monoclonal (ab6276) to b-actin at a
dilution of 1/5000, rabbit polyclonal (ab96106) to TRAM at a
dilution of 1/500, rabbit polyclonal (ab78070) to TIRAP at a
concentration of 1 mg/ml or rabbit polyclonal (ab78313) to CD14
at a concentration of 2 mg/ml overnight at 4uC. All western blot
antibodies were obtained from ABCAM (Cambridge, MA). After
incubation, the membranes were washed 3X for 15 minutes in
washing buffer (PBS-0.05% Tween20) and incubated with a
secondary anti-rabbit (b-actin, TRAM, TIRAP and CD14)
antibody coupled to horseradish peroxidase (Vector Labs,
Burlingame, CA) for 1 hour at room temperature. Then, the
membranes were washed 3X for 15 minutes in washing buffer,
and immunoreactivity was normalized by chemiluminescence
(Amersham, ECL+Plus Kit) according to the manufacturer’s
instructions. The membranes were exposed to Kodak scientific
imaging films (Rochester, NY) within 1 minute for detection.

the delta-delta method [25], with normalization for the housekeeping gene b-actin.

Immunocytochemistry
Cells cultured on non-coated glass coverslips (Fisher Scientific,
Pittsburgh, PA) at a density of ,105 cells/ml were fixed with 4%
phosphate-buffered paraformaldehyde for 15 min at RT. After
fixation, the cells were permeabilized with 0.2% Triton X-100
(Sigma, St. Louis, MO) for 5 min at RT, blocked with normal
donkey serum for 30 min and then incubated with primary mouse
monoclonal anti-human TLR4 antibody in a moist chamber for
2 hrs at RT. The cells were rinsed with PBS and incubated with
secondary FITC-conjugated goat anti-mouse IgG for 2 hrs at RT
in a dark cabinet. After several washes, coverslips containing cells
were mounted onto slides in aqueous mounting medium with antifading agents (Biomeda Corp., Foster City, CA). Fluorescence
digital images were captured using an Olympus BX60 (Melville,
NY) microscope attached with Olympus U-PMTVC camera
adaptor. Optronics DEI-750 (Goleta, CA) software was used to
acquire and analyze images. Additionally, images (maximum
intensity projection from z-stack images) were acquired using a
Zeiss LSM-510 laser scanning confocal microscope at 63X
magnification.

Measurement of Cytokines
To screen for HCMV-induced cytokine secretion, THP-1 cells
(2.56105) were incubated with media alone (negative control),
15 mg/mL of LPS from InvivoGen (positive control for IL-6 and
IL-8), or a MOI of 10 of HCMV-Toledo. IL-6, IL-8, sCD14 and
IFN-b secretion into the culture supernatants were measured by
sandwich ELISA (R&D Systems) according to the protocol from
the manufacturer. Data points are expressed as the mean optical
density (OD) of duplicate assays at 450 nm.

SDS-PAGE and Western Blot Analysis
Proteins were separated on a 10% Tris-Hcl Ready Gel (BioRad, Hercules, CA), transferred onto nitrocellulose membranes,
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Data were analyzed using the Microsoft Office Excel 2003 and
expressed as means6S.D. where appropriate. Two group comparisons were evaluated using the unpaired Student’s t-test. Values
of p,0.05 were considered statistically significant.

analysis of HCMV exposed cells reveals positive immunoreactivity
for both (C) immediate early antigens (IEA) and (D) late antigens
(LA). Images in C and D were acquired at 63X magnification and
all images are maximum intensity projection images from Z-stacks.
(TIF)
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Figure S1 Brief incubation of THP-1 cells with HCMV
leads to productive infection. Brief incubation of THP-1 cells
with HCMV for 1 to 6 hours, followed by removal of virus and
rinsing of cells, leads to HCMV infection that can be detected by
standard PCR (A) or real-time PCR (B). Immunofluorescence

Conceived and designed the experiments: CJH KY CC. Performed the
experiments: KY CC CJH RSD. Analyzed the data: KY CJH CC RSD.
Contributed reagents/materials/analysis tools: CJH. Wrote the paper: KY
CJH CC RSD.

Statistical Analysis

References
1. Sacre SM, Lundberg AM, Andreakos E, Taylor C, Feldmann M, et al. (2007)
Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA)
induced NF-kappa B activation and cytokine production in primary human cells:
TRAM is an adaptor for LPS and LTA signaling. J Immunol. 178: 2148–54.
2. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, et al. (2003) TRAM
is specifically involved in the Toll-like receptor 4-mediated MyD88-independent
signaling pathway. Nat Immunol. 4: 1144–50.
3. Tanimura N, Saitoh S, Matsumoto F, Akashi-Takamura S, Miyake K (2008)
Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in
TRIF-signaling. Biochem Biophys Res Commun. 368: 94–9.
4. Kennedy MN, Mullen GE, Leifer CA, Lee C, Mazzoni A, et al. (2004) A
complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand
for Toll-like receptor 4. J Biol Chem. 279: 34698–704.
5. Watts C (2008) Location, location, location: identifying the neighborhoods of
LPS signaling. Nat Immunol. 9: 343–5.
6. Fitzgerald KA, Chen ZJ (2006) Sorting out Toll signals. Cell. 125: 834–6.
7. Xie XH, Law HK, Wang LJ, Li X, Yang XQ, et al. (2009) Lipopolysaccharide
induces IL-6 production in respiratory syncytial virus-infected airway epithelial
cells through the toll-like receptor 4 signaling pathway. Pediatr Res. 65: 156–62.
8. Humar A, St Louis P, Mazzulli T, McGeer A, Lipton J, et al. (1999) Elevated
serum cytokines are associated with cytomegalovirus infection and disease in
bone marrow transplant recipients. J Infect Dis. 179: 484–8.
9. Akashi S, Saitoh S, Wakabayashi Y, Kikuchi T, Takamura N, et al. (2003)
Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2:
higher affinity than that with MD-2 or CD14. J Exp Med. 198: 1035–42.
10. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acutephase protein. J Immunol. 172: 4470–9.
11. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, et al. (1992) Soluble CD14
participates in the response of cells to lipopolysaccharide. J Exp Med. Dec
1;176(6): 1665–71.
12. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, et al. (2002) Essential
role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol. 3:
667–72.
13. Okumura A, Pitha PM, Yoshimura A, Harty RN (2010) Interaction between
Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of
proinflammatory cytokines and SOCS1. J Virol. 84: 27–33.

PLOS ONE | www.plosone.org
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